Dr Jane F. Barlow Discusses Potential New Reimbursement Models for New, High-Cost Therapies
I think there’s a number of different ways that payers are looking at new reimbursement models for new, high-cost therapies, said Jane F. Barlow, MD, MPH, MBA, senior advisor, Center for Biomedical Innovation at Massachusetts Institute of Technology.